Home Biosimilar Antibodies Others Others antibody Lirentelimab (Anti-Siglec-8) For research use only.
Not for use in humans.

Lirentelimab (Anti-Siglec-8)

Synonyms: AK002

Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.

Lirentelimab (Anti-Siglec-8)

Purity & Quality Control

≥99

Biological Activity

Description Lirentelimab (Anti-Siglec-8) is a humanized IgG1 monoclonal antibody that targets sialic acid-binding Ig-like lectin 8 (SIGLEC8). It can be used for the research of eosinophilic gastritis and duodenitis. MW :150 KD.

Product Details

CAS No. 2283348-97-8
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) supplier | purchase Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) cost | Lirentelimab (Anti-Siglec-8) manufacturer | order Lirentelimab (Anti-Siglec-8) | Lirentelimab (Anti-Siglec-8) distributor